Clinician Kevin Ciresi’s Takes on Europe’s $13.9B Health Tech Surge

The first quarter of 2025 sent a clear signal that investors are fully committed to European health tech. Startups across digital health and AI raised $13.9 billion in venture capital, a modest 2% increase over last year, but one that matches the previous quarter and confirms the sector's momentum.Kevin Ciresi

This influx of capital has caught the attention of individuals like Dr. Kevin Ciresi, a former surgeon who has transitioned into an operations leader. With decades of experience balancing clinical practice and healthcare business management, Ciresi sees both opportunity and warning signs in the hype.

Healthtech startups generated $4.3 billion in funding alone, up 65% year over year, and AI-enabled companies accounted for more than half of all funding, securing $3.95 billion. It marks the fourth straight quarter where health tech topped the VC charts.

"There's a lot AI can help with," Kevin Ciresi says, pointing to its use in personalizing care and interpreting large datasets. "You can match a treatment to someone's gene profile and history. That's powerful stuff."

Follow the Money

Investors aren't just local. More than 40% of the funding came from outside Europe, making Q1 2025 the best quarter for U.S. investment into the European health space since 2021. Big-ticket deals included:

• Isomorphic Labs: $600M for AI drug discovery

• Verdiva Bio: $411M in obesity-focused biotech

• Neko Health: $260M in preventive care

AI startups raised an average of $34.4 million per round, nearly double the $18.8 million average for non-AI startups. The takeaway? Investors are placing significant bets on tools that promise to address longstanding healthcare bottlenecks.

Kevin Ciresi imagines a system where anonymized patient data feeds more intelligent clinical decision-making: "AI could flag options based on a patient's history and the outcomes of people like them. Then the clinician makes the call from there." His background in healthcare operations gives him insight into where technology can genuinely improve patient outcomes.

AI's Potential on Diagnosis

AI is making fast inroads in diagnostics, especially in radiology and pathology. Kevin Ciresi agrees that radiology is ripe for disruption.

"It can scan images faster than a human, and sometimes down to the pixel," he says. But he's quick to add a caveat: "There still must be oversight. You need that second set of eyes, and you need, more importantly, judgment."

That judgment is what concerns him most. AI imaging tools are maturing, and there are widely approved AI applications in healthcare, with over 1,000 FDA-cleared algorithms, primarily targeting radiology. In breast and lung cancer screening, AI-assisted imaging has improved detection rates and reduced the number of false negatives. Accuracy rates for specific tasks (e.g., lung nodule detection) have reached 90–94%, often outperforming human radiologists in controlled studies. To apply these processes to more complex situations requires oversight and sound judgment in real-world applications.

Fixing the Admin Mess

Kevin Ciresi lights up when the conversation turns to reducing administrative headaches, a challenge he faced during his surgical career. His transition from surgery to operations documents how these operational inefficiencies drove him to focus on healthcare systems improvement.

"I'd have two or three feet of charts on my desk at the end of the day," he says. "Then I'd have to sit there and dictate every note. It was ridiculous."

It's not just doctors feeling the squeeze. "Nurses have it even worse," he adds. The dream solution? "You walk in, the whole thing's recorded and transcribed. That's your note."

UK-based TORTUS AI is heading in that direction, developing tools to ease digital workloads and reduce burnout. It raised €4 million to support rollout in national health systems.

Cautionary Perspectives on Over-Reliance

Ciresi's optimism is tempered by experience. He sees a few major red flags when it comes to leaning too hard on AI in medicine:

1. Bad input = bad output: "It can be wrong. You're pulling from limited data."

2. Loss of clinical judgment: "You stop thinking. It becomes a crutch."

3. No one knows how it works: "Even the people who built it can't explain it. That's scary."

   
   

He recalls moments in his career when intuition saved a patient. "I've had cases where something didn't sit right. The textbook said one thing, I thought another, and I was right." In his analysis of boardroom versus exam room dynamics, Ciresi explores this tension between data-driven decisions and clinical intuition.

His concern isn't just about tools today, but how they shape tomorrow's clinicians. "We had to come up with a differential diagnosis, thereby thinking through the human part of the process. Now you plug symptoms into a computer and get an answer. That's not the same thing."

European Policy Framework and Investment Infrastructure

The EU is placing significant emphasis on AI and digital health. Between 2024 and 2027, up to €4 billion will be allocated for the deployment of AI. A dedicated European AI Office was launched in early 2024 to enforce the new AI Act, one of the first comprehensive regulations of AI.

This April, the EU unveiled its AI Continent Action Plan, backed by a €500 million GenAI4EU program aimed at bolstering Europe's global AI leadership. Healthcare innovators and entrepreneurs like Ciresi are watching these developments closely, understanding how policy shapes innovation opportunities.

More numbers:

• €14B from EU member states for digital health under the Recovery and Resilience Facility

• €810M from the European Commission through various programs

• €11B in estimated savings over 10 years from better data sharing and use

Funding in digital health rebounded in 2024, primarily driven by the AI wave, with $5.7 billion raised in the first half of the year alone.

Market Maturation and Future Outlook

Healthcare faces pressure from aging populations, burnout, and rising demand for mental health services. Investors see AI as the solution. But Kevin Ciresi's view is clear: the excitement is justified, yet safeguards are essential. His startup advisory work reflects this balanced approach to healthcare innovation.

"I switched to operations because I thought I could help fix some of what wasn't working," he says. "But you can't fix it by removing clinical and critical thinking."

Q1's $13.9 billion investment boom is more than just headlines. It's a bet that technology can finally address some of healthcare's biggest challenges. Whether it succeeds will depend on how well the industry listens to experienced clinicians like Ciresi, who bring both scientific expertise and a deep understanding of the systems. His insights on healthcare transformation offer valuable perspectives for investors and innovators alike.

"I think AI's just another tool," he says. "And like any tool, it depends on how you use it."